Delivery Order SPE2DB24D8002-SPE2DB25FJNDU
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,563,714,305 units of Vyvanse 40 mg capsules. The contract has a ceiling value of $2,237.18 and a completion date of February 21, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a single-award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,946.91 firm fixed-price contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of November 7, 2023. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,563,570 units of VYVANSE 50 MG CAPSULE 100S, a pharmaceutical product. The contract has a firm fixed price of $2,849.87 and a completion date of February 7, 2024. The contract is not a set-aside and is an unrestricted award. Dakota Drug, Inc. is an experienced federal contractor,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,461.76 firm-fixed-price contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a completion date of February 7, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT...
The Defense Logistics Agency (DLA) awarded a $1,461.18 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4,565,228,290 units of the prescription medication Vyvanse 50 mg capsules. This order falls under Dakota Drug's Indefinite Delivery Contract (IDC) SPE2DB24D8001 with DLA Troop Support Medical, a $999,999,999.00 single-award contract that enables the company to supply a range of pharmaceutical products, medical supplies,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The award, valued at $1,341.22, is for the provision of 10 mg Vyvanse capsules (100 count) to support medical supply chain operations for the U.S. Armed Forces. The contract has a completion date of May 15, 2024 and was awarded on May 14, 2024 without the use of a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,948.24, is for the delivery of 4,564,623,874 units of the prescription medication Vyvanse 20 mg capsules. The contract has a performance period ending on May 16, 2024 and was awarded on May 15, 2024 without any set-aside designation. Dakota Drug, Inc. is an experienced prime...
The Defense Logistics Agency (DLA) awarded a $1,184.36 firm fixed-price delivery order contract to Dakota Drug, Inc., a small disadvantaged business. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a prescription medication. This delivery order falls under Dakota Drug, Inc.'s $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical...
This is a $2,157.72 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, with a period of performance ending on November 25, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $6,972.64 firm fixed-price contract is for the supply of 100 count bottles of the prescription medication VYVANSE 70 MG CAPSULES. This delivery order is associated with Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...